Gumbleton M, Nicholls P J, Taylor G
Welsh School of Pharmacy, UWIST, Cardiff, U.K.
Arch Int Pharmacodyn Ther. 1988 Jul-Aug;294:7-32.
With the aim of examining the possible basis to i.p. urethane anaesthesia-induced reductions in renal clearance, this study has investigated: (a) the influence that some anaesthetic regimens may have on the renin-angiotensin system (RAS); and (b) the ability of these anaesthetic regimens to initiate intraperitoneal toxicity. In the rat, i.p. urethane anaesthesia, compared with pentobaritone i.p. and "Hypnorm/Hypnovel" i.p. anaesthesia, resulted in significantly lower mean arterial pressure (MAP) and elevations in plasma renin activity (PRA) in both surgically-prepared and surgically-intact animals. Urethane anaesthesia also produced intraperitoneal toxicity, which was characterized by a greater peritoneal fluid volume and peritoneal cavity total protein content. The elevated protein content in the peritoneal cavity resulted in part from plasma leakage from the vascular compartment, as demonstrated by i.v. Evans' blue dye studies. Intraperitoneal toxicity was absent following administration of urethane by either i.v. or oral routes. A reduction in systemic perfusion pressure and an elevation in renal vascular resistance, via activation of the RAS are likely to be responsible for i.p. urethane-induced reductions in renal clearance. Intraperitoneal toxicity is likely, only in part, to be responsible for such changes.
为了探究腹腔注射氨基甲酸乙酯麻醉导致肾清除率降低的可能原因,本研究调查了:(a) 某些麻醉方案对肾素 - 血管紧张素系统 (RAS) 的影响;以及 (b) 这些麻醉方案引发腹腔毒性的能力。在大鼠中,与腹腔注射戊巴比妥和腹腔注射 “海洛因/氟哌利多” 麻醉相比,腹腔注射氨基甲酸乙酯麻醉在手术准备和未手术的动物中均导致平均动脉压 (MAP) 显著降低以及血浆肾素活性 (PRA) 升高。氨基甲酸乙酯麻醉还产生了腹腔毒性,其特征是腹腔液体积和腹腔总蛋白含量增加。腹腔中蛋白质含量升高部分是由于血管腔血浆渗漏所致,静脉注射伊文思蓝染料研究证明了这一点。静脉注射或口服氨基甲酸乙酯后未出现腹腔毒性。通过激活 RAS 导致全身灌注压降低和肾血管阻力升高可能是腹腔注射氨基甲酸乙酯引起肾清除率降低的原因。腹腔毒性可能只是部分导致了这种变化。